• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC OCTARAY, PERSEID, 48P, 2-2-2-2-2, D-CURVE; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC OCTARAY, PERSEID, 48P, 2-2-2-2-2, D-CURVE; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY Back to Search Results
Model Number D160901
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Visual Impairment (2138); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/25/2023
Event Type  Injury  
Event Description
It was reported from a bwi sponsored study that a patient underwent paroxymal afib cardiac ablation procedure that included the use of octaray, perseid, 48p, 2-2-2-2-2, d-curve mapping catheter.The patient experienced intermittent scotoma (ae1) that required hospitalization.External reference: (b)(4).Index procedure on (b)(6) 2023 with general anesthesia that included a double transseptal access and pre-ablation mapping of la with octaray, perseid, 48p, 2-2-2-2-2, d-curve catheter that included left superior pulmonary vein (lspv), left inferior pulmonary vein (lipv), right superior pulmonary vein (rspv), and right inferior pulmonary vein (ripv).Ablation was performed on lpv and rpv for pvi.During rpv ablation with the ablation catheter an impedance error was noted.On (b)(6) 2023, patient experienced intermittent scotoma (ae1) and visited the emergency room.The study principal investigator (pi) categorized the event severity as moderate and serious as defined by inpatient or prolonged hospitalization with admission of (b)(6) 2023 and discharge of (b)(6) 2023.Per pi, relationship to biosense webster ce mark devices octaray catheter is possible; and relationship to study procedure is possible.The event is categorized as expected/anticipated and the outcome is not recovered/not resolved.No specific intervention/treatment was provided.It is noted that the patient visited the emergency room on (b)(6) 2023 and marked as admitted for same adverse event of intermittent scotoma (ae1).No further information provided about this event.
 
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
On 04-may-2023 and 26-may-2023, additional information was received indicating that the adverse event (ae1) term of intermittent scotoma was updated to migraine aura.The adverse event is not related to any devices and not related to the study procedure.As such, this event is no longer considered to be mdr reportable.Therefore, the h 6.Health effect - clinical code, h 6.Health effect - impact code and h 6.Medical device problem code were updated.Since this event has already been reported to fda, biosense webster inc.Will continue to submit supplemental 3500a reports to the fda with any updates even though this event is no longer considered mdr reportable.An analysis of the product could not be performed since a physical sample was not received for evaluation.A manufacturing record evaluation was performed for the finished device 30997447l number, and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number:(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OCTARAY, PERSEID, 48P, 2-2-2-2-2, D-CURVE
Type of Device
CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key16811985
MDR Text Key313989145
Report Number2029046-2023-00885
Device Sequence Number1
Product Code MTD
UDI-Device Identifier10846835021141
UDI-Public10846835021141
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K193237
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD160901
Device Catalogue NumberD160901
Device Lot Number30997447L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/27/2023
Initial Date FDA Received04/25/2023
Supplement Dates Manufacturer Received05/04/2023
Supplement Dates FDA Received06/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
THCL SMTCH SF BID TC, D-F, IDE; TRUPULSE GENERATOR, WW
Patient Outcome(s) Hospitalization;
Patient Age57 YR
Patient SexMale
Patient Weight87 KG
-
-